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Introduction: Prostatic hyperplasia is the most frequent tumor in men older than 50 years of age. Bilateral
hydronephrosis secondary to benign prostatic hypertrophy is a rare condition most often due to vesicoureteral
reflux. Herein we report a case of a patient with bilateral hydronephrosis with distal ureter obstruction caused by
detrusor hypertrophy due to prostatic hyperplasia, our analysis of the clinical data and a review of the relevant
published literature.
Case presentation: We report a case of a 65-year-old Berber man with clinically significant storage, bladder-emptying
symptoms and bilateral low back pain with renal biologic failure and bilateral ureterohydronephrosis, distal ureteral
stenosis, detrusor hypertrophy and prostate hyperplasia without significant post-void residual urine volume visualized
by abdominal sonography. The patient underwent bilateral JJ stent insertion with transurethral resection of the
prostate. The patient was discharged 3 days after surgery without any obvious complications. At his 3-month follow-up
examination, the JJ stent was removed and the patient had comfortable urination without renal failure.
Conclusion: This is an extremely rare condition that has important diagnostic considerations because of the possibility
of comorbid severe obstructive uropathy and chronic renal failure.
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Benign prostatic hyperplasia (BPH) is the most common
benign tumor in men. BPH is the growth of epithelial,
muscular and/or fibrotic cells in the prostate [1] and is
responsible for the occurrence of urinary symptoms in
men older than 50 years of age. It is clinically manifested
by a low obstructive uropathy syndrome, which includes
storage and voiding symptoms, and is diagnosed on the
basis of an adequate digital rectal examination (DRE),
prostate and bladder ultrasound and prostate-specific
antigen (PSA) level. In a complementary form, urinary
flowmetry, cystoscopy and transrectal ultrasound can be
tested, in addition to biopsy [2,3]. Intravenous urography* Correspondence: riyach2@hotmail.com
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reproduction in any medium, provided the or(IVU) is a radiological tool for the assessment of BPH-
related changes of the upper and lower urinary tracts
(for example, hydronephrosis, trabeculation, diverticula
and bladder stones) and other urological diseases (for
example, nephro- and ureterolithiasis and upper urinary
tract tumors). It has been abandoned in routine work-up
of patients with BPH because of increased radiation risks,
costs and little additional diagnostic benefit compared to
ultrasonography [4,5]. However, it is still a valid tool to
use to evaluate upper urinary tract modification associated
to BPH, and an important diagnostic tool in cases of
bilateral hydronephrosis without post-void residual (PVR),
which is an extremely rare complication of this pathology
that has been described in a few reported cases in the
literature. So, herein we report a case of a patient with
bilateral hydronephrosis with distal ureter obstruction
caused by detrusor hypertrophy due to prostatic hyperplasia.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Figure 2 Renal ultrasound images showing two bilateral
ureterohydronephroses. REIN DROIT: right kidney; REIN GAUCHE:
left kidney.Case presentation
We report the case of a 65-year-old Berber man admitted
to our urology department because of renal failure.
He had a history of symptoms of bladder fullness and
emptying with a 1-year evolution characterized by decreased
force and caliber of the urine stream, intermittency, dysuria,
frequent urge to urinate, urgency and terminal dribbling
with nightly urination (three to five times). The evolution
of his symptoms included acute urinary retention 1 month
prior to urological testing. During the patient’s medical
history interview, he referred to chronic lumbar pain but
no weight loss. During the physical examination, his full
bladder was found not to be palpated, his genitals were
adequate for age and sex and a DRE revealed a normo-
tonic sphincter. His prostate was enlarged and had an
adenomatous surface. The routine laboratory findings
revealed biologic renal failure with the following laboratory
panel values: urea 43.5mg/dl, creatinine 0.8mg/dl, sodium
144mEq/L, potassium 4.5mEq/L, chloride 118mEq/L and
free PSA 4.12ng/ml. An abdominal ultrasound confirmed
prostatic enlargement, estimated at 45ml with regular
edges, good definition of homogeneous echogenicity
and regular bladder wall thickness hypertrophy (Figure 1).
Another image showed bilateral ureterohydronephrosis
(Figure 2), and PVR urine volume was found to be 35ml.
Uroflowmetry demonstrated maximum urinary flow rate
and average urinary flow rate to be 13ml/s. Our investiga-
tions were completed with drip infusion pyelography,
which showed significant dilatation of the upper urinary
tract and a partial defect of the distal ureter (Figure 3).
The patient underwent bilateral JJ stent insertion with
transurethral resection of the prostate. The Foley catheterFigure 1 Bladder ultrasound showing trabeculation and bladder
wall thickening.was removed after 2 days, after which the patient was able
to void without difficulty. The patient was discharged 3
days after surgery without any obvious complications. A
pathologic examination revealed benign prostatic gland
hyperplasia. At the patient’s 3-month follow-up examin-
ation, his JJ stent was removed. He had comfortable
urination without renal failure.
Discussion
BPH is a common problem experienced by aging men
that can lead to serious outcomes, including acute urinary
retention and bladder stone formation. Its prevalence is
directly proportional to increase in age. At 80 years of age,
its prevalence is 95% [3]. These prostatic changes begin at
40 years of age, and prostate volume increases by around
0.6ml/yr and is associated with a reduction of mean urin-
ary flow at the rate of 0.2ml/s [6]. This is not necessarily
definitive, because prostate growth and the severity of its
symptoms are erratic in the patient population. Known
as prostatism, this constellation of clinical symptoms is
characterized by the presence of irritable and obstructive
Figure 3 Drip infusion pyelogram showing important dilatation of
the upper urinary tract with a partial defect of the distal ureter.
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general manner on the basis of the International Prostate
Symptom Score. Chronic or acute obstructive renal failure
is a serious condition associated with premature mortality,
decreased quality of life and increased health-care ex-
penditures. Both diseases are extremely common among
aging men, leading some to suggest that it is a natural
concomitant of aging. Nonetheless, quite recently, evidence
of an association between BPH and chronic kidney disease
(CKD) has arisen in two different studies. In a study by
Yamasaki et al. [7], the PVR of patients with CKD was
significantly greater than that of patients without CKD,
and the presence of PVR urine was independently associ-
ated with CKD, indicating a close association between
CKD and residual urine. In that study, PVR was used as a
surrogate measure of bladder outlet obstruction and thus
of urodynamically relevant BPH [7]. Yamasaki et al. re-
ported a higher prevalence (31.8%) of CKD among BPH
patients than those without BPH. Although the prevalence
of CKD can be considered relatively low among men with
BPH, the possibility of CKD should be considered in those
who have a low maximum flow rate and obstructive
urinary symptoms. Chronic urinary retention is thought
to be the dominant mechanism by which BPH can cause
chronic renal failure, Rule et al. defined chronic urinary
retention (CUR) as PVR urine levels higher than 100ml
and reported that CUR was significantly associated in
CKD in community-dwelling men [8-10].
For years, it has been well-described that large urinary
volume (greater than 300ml) affects renal function inpatients with advanced BPH. To the best of our knowledge,
the case of our patient involved the largest urinary volume
reported in the literature. In our patient, the ureterovesical
junction obstruction caused by detrusor hypertrophy seems
to have been the principal contributing factor to renal fail-
ure in BPH. Upper tract dilation occurs as a consequence
of a continuum of bladder outlet obstruction and remod-
eling (detrusor hypertrophy and scarring), leading to ana-
tomical ureterovesical junction obstruction. Upper urinary
tract dilation or hydronephrosis is consistent with chronic
renal failure due to obstructive uropathy. In men with
BPH and increased serum creatinine levels, hydronephro-
sis is common (occurring in one-third of patients), with a
prevalence of 90% in men with BPH who are hospitalized
for uremic symptoms. In ultrasound evaluation of patients
with bilateral hydroureteronephrosis, it is common to
observe compressing and thinning of the renal cortex
with obvious impact on renal function. Imaging studies
are an excellent diagnostic tool. These tools include
ultrasonography and excretory urography. Because IVU
has not routinely been conducted in patients with creatin-
ine levels (180mmol/L), patients without impaired renal
function still represent the best examples for showing
this relationship by revealing bilateral upper urinary tract
dilation with regular ureterovesical junction obstruction.
Transurethral resection of the prostate is still the gold
standard treatment of benign prostatic hypertrophy, even
in cases with associated hydronephrosis and ureterovesical
junction obstruction caused by detrusor hypertrophy [11].
The surgical treatment options for BPH have dramatically
changed with the development of minimally invasive ther-
apies over the past two decades. They include holmium
laser enucleation of the prostate, transurethral electro-
vaporization of the prostate, transurethral microwave
thermotherapy and other modalities [11]. However, these
techniques are also performed in patients with slightly to
moderately enlarged prostates. Rocco et al. stated that
100ml is regarded as the prostate weight limit for those
minimally invasive procedures [12]. European Association
of Urology guidelines state that open prostatectomy is the
treatment of choice for large prostate glands more than
80ml to 100ml in size [13]. If ureterohydronephrosis and
azotemia persist despite bladder unblocking, ureterovesical
junction obstruction should be considered, and bilateral
percutaneous nephrostomy or bilateral ureteric stents are
advisable for temporary drainage, as we have reported in
our present case. We think that our case is interesting and
rare, particularly with regard to the patient’s lumbar pain
due to bilateral ureterohydronephrosis as the first and
principal symptom of benign prostatic hypertrophy.
Conclusion
The physiological causes that lead to the ureterovesical
junction obstruction in BPH are still incompletely known.
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treatment are important because of its association with se-
vere obstructive uropathy and chronic renal insufficiency.
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